1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Advancing Progress in Survivorship" is currently closed and not accepting applications.
Advancing Progress in Survivorship is sponsored by Breast Cancer Canada + AstraZeneca Canada. This funding supports innovative, Canadian-led research focused on improving breast cancer survivorship care across Canada. It addresses critical gaps following primary treatment, with an emphasis on real-world impact and improved patient outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Research must be conducted in Canada. No institutional overhead permitted. Specific eligibility details for applicants (e. g. , individual researchers, institutions) would likely be in the application package. Confirm the full requirements in the official notice before applying.
The current listing shows 2 awards of $100,000 CAD each. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was July 31, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Advancing Progress in Survivorship is funded by Breast Cancer Canada + AstraZeneca Canada. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read article